Autolus Therapeutics (AUTL) Assets (2017 - 2026)
Autolus Therapeutics' (AUTL) quarterly Assets came in at $589.1 million in Q4 2025, down 24.74% YoY from $782.7 million in Q4 2024, and down 11.01% on a QoQ basis from $661.9 million in Q3 2025.
Autolus Therapeutics (AUTL) Assets (2017 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 9 years of Assets data on file, last reported at $589.1 million in Q4 2025.
- Quarterly Assets fell 24.74% year-over-year to $589.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $589.1 million (down 24.74% YoY) and the FY2025 annual result came in at $589.1 million, down 24.74% from the prior year.
- Assets slipped to $589.1 million in Q4 2025, from $661.9 million in the prior quarter.
- In the past five years, Assets ranged from a high of $901.4 million in Q1 2024 to a low of $263.8 million in Q3 2022.
- A 5-year average of $529.5 million and a median of $455.5 million in 2023 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets surged 108.51% — and 2025, when it slipped 24.74%.
- Tracing AUTL's Assets over 5 years: stood at $405.6 million in 2021, then gained by 20.89% to $490.3 million in 2022, then fell by 23.43% to $375.4 million in 2023, then soared by 108.51% to $782.7 million in 2024, then fell by 24.74% to $589.1 million in 2025.
- The last three Assets figures came in at $589.1 million (Q4 2025), $661.9 million (Q3 2025), and $721.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | 493.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 493.23 Mn |
| Dec 31, 2025 | 589.07 Mn |
| Sep 30, 2025 | 661.95 Mn |
| Jun 30, 2025 | 720.98 Mn |
| Mar 31, 2025 | 746.34 Mn |
| Dec 31, 2024 | 782.73 Mn |
| Sep 30, 2024 | 827.49 Mn |
| Jun 30, 2024 | 853.62 Mn |
| Mar 31, 2024 | 901.44 Mn |
| Dec 31, 2023 | 375.38 Mn |
| Sep 30, 2023 | 406.10 Mn |
| Jun 30, 2023 | 450.99 Mn |
| Mar 31, 2023 | 459.97 Mn |
| Dec 31, 2022 | 490.27 Mn |
| Sep 30, 2022 | 263.83 Mn |
| Jun 30, 2022 | 313.98 Mn |
| Mar 31, 2022 | 363.99 Mn |
| Dec 31, 2021 | 405.56 Mn |
| Sep 30, 2021 | 296.64 Mn |
| Jun 30, 2021 | 330.66 Mn |